Rosalia Bertorelli Selected Research

Rosalia Bertorelli Research Topics

Disease

11	Pain (Aches) 02/2014 - 08/2002
6	Wounds and Injuries (Trauma) 02/2022 - 06/2017
6	Hyperalgesia 03/2013 - 06/2002
5	Chronic Pain 12/2012 - 02/2005
5	Neuralgia (Stump Neuralgia) 02/2012 - 06/2002
3	Burns 01/2022 - 03/2016
3	Parkinson Disease (Parkinson's Disease) 07/2009 - 03/2007
2	Neoplasms (Cancer) 01/2022 - 01/2020
2	Inflammation (Inflammations) 03/2013 - 05/2012
2	Cognitive Dysfunction 01/2013 - 01/2012
2	Amnesia (Dissociative Amnesia) 01/2013 - 01/2012
2	Mental Disorders (Mental Disorder) 07/2009 - 04/2005
2	Catalepsy 02/2009 - 03/2007
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2021
1	COVID-19 07/2021
1	Glioblastoma (Glioblastoma Multiforme) 02/2021
1	Neuroblastoma 12/2020
1	Leukemia 11/2020
1	Cystic Fibrosis (Mucoviscidosis) 10/2020
1	Down Syndrome (Down's Syndrome) 08/2020
1	Brain Diseases (Brain Disorder) 08/2020
1	Autistic Disorder (Autism) 08/2020
1	Neuroinflammatory Diseases 05/2020
1	Autism Spectrum Disorder 01/2018
1	Erythema 03/2016
1	Nociceptive Pain 02/2014
1	Alzheimer Disease (Alzheimer's Disease) 01/2013
1	Arthritis (Polyarthritis) 05/2012
1	Peripheral Nerve Injuries 05/2012

Drug/Important Bio-Agent (IBA)

6	metabotropic glutamate receptor type 1IBA 12/2012 - 04/2005
5	Pharmaceutical PreparationsIBA 01/2022 - 04/2009
4	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 07/2009 - 01/2003
2	Povidone (Crospovidone)IBA 02/2022 - 06/2017
2	AlginatesIBA 01/2022 - 03/2016
2	PoisonsIBA 11/2020 - 01/2020
2	Formaldehyde (Formol)FDA Link 02/2014 - 04/2005
2	CarrageenanIBA 03/2013 - 05/2012
2	Scopolamine (Hyoscine)FDA Link 01/2013 - 01/2012
2	Gabapentin (Neurontin)FDA LinkGeneric 05/2012 - 12/2011
2	Analgesics (Analgesic Drugs)IBA 05/2012 - 11/2011
2	Purinergic P2X7 ReceptorsIBA 12/2011 - 06/2011
2	2- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA 07/2009 - 02/2009
2	pyrimidineIBA 02/2009 - 03/2007
2	Haloperidol (Haldol)FDA LinkGeneric 02/2009 - 03/2007
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 11/2007 - 04/2005
2	5- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA 03/2007 - 01/2003
1	Hyaluronic Acid (Hyaluronan)IBA 02/2022
1	SerpinsIBA 01/2022
1	Prion ProteinsIBA 01/2022
1	AntioxidantsIBA 01/2022
1	PrionsIBA 01/2022
1	GTP Phosphohydrolases (GTPases)IBA 01/2022
1	Free RadicalsIBA 01/2022
1	ARN22089IBA 01/2022
1	Soaps (Soap)IBA 07/2021
1	Disinfectants (Biocides)IBA 07/2021
1	LipidsIBA 02/2021
1	OxazolesIBA 12/2020
1	EnzymesIBA 11/2020
1	Chloride Channels (Chloride Channel)IBA 10/2020
1	DiureticsIBA 08/2020
1	Ellagic AcidIBA 05/2020
1	Cell Adhesion MoleculesIBA 01/2018
1	Biopolymers (Biopolymer)IBA 01/2018
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	LipopolysaccharidesIBA 01/2018
1	tyrosine receptor (receptor, tyrosine)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	PolymersIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2017
1	Acetic Acid (Vinegar)FDA LinkGeneric 06/2017
1	methylallyl trisulfide (MATS)IBA 06/2017
1	Ciprofloxacin (Cipro)FDA LinkGeneric 06/2017
1	Sodium CompoundsIBA 03/2016
1	CytokinesIBA 03/2016
1	lavender oilIBA 03/2016
1	AcidsIBA 03/2013
1	N-acylethanolaminesIBA 03/2013
1	GW 6471IBA 03/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2013
1	5-phenylpentyl N- ((2S,3R)- 2- methyl- 4- oxo- oxetan- 3- yl)carbamateIBA 03/2013
1	amidaseIBA 03/2013
1	Peptides (Polypeptides)IBA 01/2013
1	memoquinIBA 01/2013
1	Amyloid beta-PeptidesIBA 01/2013
1	Nootropic Agents (Nootropics)IBA 01/2013
1	Indomethacin (Indometacin)FDA LinkGeneric 05/2012
1	URB937IBA 05/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2012
1	Freund's AdjuvantIBA 05/2012
1	Memantine (Namenda)FDA Link 01/2012
1	Galantamine (Galanthamine)FDA LinkGeneric 01/2012

Therapy/Procedure

7	Ligation 03/2013 - 06/2002
2	Oral Administration 12/2020 - 05/2020
1	Drug-Eluting Stents 07/2021
1	Topical Administration 03/2013